Integrating external beam and prostate seed implant dosimetry for intermediate and high-risk prostate cancer using biologically effective dose: Impact of image registration technique-Reference-Cited by-同舟云学术

Integrating external beam and prostate seed implant dosimetry for intermediate and high-risk prostate cancer using biologically effective dose: Impact of image registration technique

Published:2022-11 Issue:6 Volume:21 Page:853-863
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Riegel Adam C.,Cooney Ann,To Samantha,Guest Deborah,Lee Brisca,Lim May,Potters Louis

Funder

Varian Medical Systems

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference53 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: the impact of Gleason pattern 5;Liss;Brachytherapy,2015

3. Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer;Spratt;BJU Int,2014

4. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy;Stone;Int J Radiat Oncol Biol Phys,2009

5. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer;Shilkrut;Cancer,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity;Advances in Radiation Oncology;2023-05